Calprotectin, a faecal marker of organic gastrointestinal abnormality

被引：117

作者：

Fagerhol, MK ^{[1
]}

机构：

[1] Ullevaal Univ Hosp, Dept Immunol & Transfus Med, N-0407 Oslo, Norway

来源：

LANCET | 2000年 / 356卷 / 9244期

关键词：

D O I：

10.1016/S0140-6736(00)03224-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1783 / 1784

页数：2

共 18 条

[1] Screening with stable faecal proteins - Can they exclude GI pathology? [J].

Campbell, SS ;

Brydon, G ;

Anderson, N ;

Ghosh, S .

GASTROENTEROLOGY, 2000, 118 (04) :A103-A103

[2]

Fagerhol M. K., 1990, STIMULUS RESPONSE CO, P187

[3]

Fagerhol MK, 1996, J CLIN PATHOL-CL MOL, V49, pM74

[4]

FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393

[5] Fecal marker variability in colorectal cancer: Calprotectin versus hemoglobin [J].

Gilbert, JA ;

Ahlquist, DA ;

Mahoney, DW ;

Zinsmeister, AR ;

Rubin, J ;

Ellefson, RD .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (10) :1001-1005

[6]

Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113

[7] Fecal calprotectin concentration in patients with colorectal carcinoma [J].

Kristinsson, J ;

Roseth, A ;

Fagerhol, MK ;

Aadland, E ;

Schjonsby, H ;

Bormer, OP ;

Raknerud, N ;

Nygaard, K .

DISEASES OF THE COLON & RECTUM, 1998, 41 (03) :316-321

[8] Faecal calprotectin levels in a high risk population for colorectal neoplasia [J].

Kronborg, O ;

Ugstad, M ;

Fuglerud, P ;

Johne, B ;

Hardcastle, J ;

Scholefield, JH ;

Vellacott, K ;

Moshakis, V ;

Reynolds, JR .

GUT, 2000, 46 (06) :795-800

[9] Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs [J].

Meling, TR ;

Aabakken, L ;

Roseth, A ;

Osnes, M .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) :339-344

[10]

Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50

← 1 2 →